These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21737201)

  • 1. Comment on: Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study, by Ernberg, Hedenberg-Magnusson, List, and Svensson.
    Janal MN; Raphael KG
    Pain; 2011 Sep; 152(9):2186-2187. PubMed ID: 21737201
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study.
    Ernberg M; Hedenberg-Magnusson B; List T; Svensson P
    Pain; 2011 Sep; 152(9):1988-1996. PubMed ID: 21514731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BTX-A for persistent myofascial TMD pain: interpreting a small clinical trial with negative results.
    Nixdorf DR
    Pain; 2011 Sep; 152(9):1944-1945. PubMed ID: 21641114
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.
    Yoshida K
    Toxins (Basel); 2021 Aug; 13(9):. PubMed ID: 34564609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localized myofascial pain responds better than referring myofascial pain to botulinum toxin injections.
    Abboud WA; Hassin-Baer S; Joachim M; Givol N; Yahalom R
    Int J Oral Maxillofac Surg; 2017 Nov; 46(11):1417-1423. PubMed ID: 28521968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin therapy for temporomandibular joint disorders: a systematic review of randomized controlled trials.
    Chen YW; Chiu YW; Chen CY; Chuang SK
    Int J Oral Maxillofac Surg; 2015 Aug; 44(8):1018-26. PubMed ID: 25920597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of small doses of botulinum toxin a on neck-shoulder myofascial pain syndrome: a double-blind, randomized, and controlled crossover trial.
    Ojala T; Arokoski JP; Partanen J
    Clin J Pain; 2006 Jan; 22(1):90-6. PubMed ID: 16340597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of botulinum toxin in patients with myofascial pain related to temporomandibular joint disorders: A systematic review.
    Ramos-Herrada RM; Arriola-Guillén LE; Atoche-Socola KJ; Bellini-Pereira SA; Castillo AA
    Dent Med Probl; 2022; 59(2):271-280. PubMed ID: 35775414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical review of the use of botulinum toxin in orofacial pain disorders.
    Clark GT; Stiles A; Lockerman LZ; Gross SG
    Dent Clin North Am; 2007 Jan; 51(1):245-61, ix. PubMed ID: 17185069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin in the management of temporomandibular disorders: a systematic review.
    Thambar S; Kulkarni S; Armstrong S; Nikolarakos D
    Br J Oral Maxillofac Surg; 2020 Jun; 58(5):508-519. PubMed ID: 32143934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Effects of a Single Application of Botulinum Toxin Type A in Temporomandibular Myofascial Pain Patients: A Controlled Clinical Trial.
    De la Torre Canales G; Câmara-Souza MB; Poluha RL; de Figueredo OMC; Nobre BBS; Ernberg M; Conti PCR; Rizzatti-Barbosa CM
    Toxins (Basel); 2022 Oct; 14(11):. PubMed ID: 36355991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Use of Botulinum Toxin for the Treatment of Myofascial Pain in the Masticatory Muscles.
    Laskin DM
    Oral Maxillofac Surg Clin North Am; 2018 Aug; 30(3):287-289. PubMed ID: 30008341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Localized and Referred Masticatory Myofascial Pain with Botulinum Toxin Injection.
    Montes-Carmona JF; Gonzalez-Perez LM; Infante-Cossio P
    Toxins (Basel); 2020 Dec; 13(1):. PubMed ID: 33374687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome.
    Wheeler AH; Goolkasian P; Gretz SS
    Spine (Phila Pa 1976); 1998 Aug; 23(15):1662-6; discussion 1667. PubMed ID: 9704373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, controlled, randomized trial to evaluate the efficacy of botulinum toxin for the treatment of lumbar myofascial pain in humans.
    De Andrés J; Adsuara VM; Palmisani S; Villanueva V; López-Alarcón MD
    Reg Anesth Pain Med; 2010; 35(3):255-60. PubMed ID: 20921836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin A for myofascial trigger point injection: a qualitative systematic review.
    Ho KY; Tan KH
    Eur J Pain; 2007 Jul; 11(5):519-27. PubMed ID: 17071119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin A (Botox) for treatment of proximal myofascial pain in complex regional pain syndrome: two cases.
    Safarpour D; Jabbari B
    Pain Med; 2010 Sep; 11(9):1415-8. PubMed ID: 20735753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin for myofascial pain syndromes in adults.
    Soares A; Andriolo RB; Atallah AN; da Silva EM
    Cochrane Database Syst Rev; 2012 Apr; (4):CD007533. PubMed ID: 22513950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of PrabotulinumtoxinA (Nabota
    Kim DY; Kim JM
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30177597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated tender point injections of granisetron alleviate chronic myofascial pain--a randomized, controlled, double-blinded trial.
    Christidis N; Omrani S; Fredriksson L; Gjelset M; Louca S; Hedenberg-Magnusson B; Ernberg M
    J Headache Pain; 2015; 16():104. PubMed ID: 26634569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.